USPTO serial 79350535
ALEVATE
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Dec 3, 2024
- Examiner
- PERKINS, ELLEN J
- Law office
- FILE REPOSITORY (FRANCONIA)
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with ALEVATE?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Karen Lim
Karen Lim Fross Zelnick Lehrman & Zissu, P.C.151 West 42nd St., 17th FLNew York, NY 10036United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 041 | Education, namely, classes, seminars, and workshops in the fields of biology, medicine, biologicals, biopharmaceuticals, pharmaceuticals, and chemical analysis; providing of training in the fields of biology, medicine, biologicals, biopharmaceuticals, pharmaceuticals, and chemical analysis; teaching and training in the fields of biology, medicine, biologicals, biopharmaceuticals, pharmaceuticals and chemical analysis; teaching and training in the fields of development and use of vaccines, growth factors, immune modulators, monoclonal antibodies, cells, cell therapies, tissues, proteins, recombinant proteins, nucleic acids, gene therapies, products derived from living culture systems, products derived from human blood, products derived from plasma; provision of medical, biological, biopharmaceutical, pharmaceutical and chemical instruction courses; organization of educational conferences in the fields of medical, biological, biopharmaceutical, pharmaceutical and chemical research and development; technical training in the field of medical, biological, biopharmaceutical, pharmaceutical and chemical analysis; information, consultancy and advisory services for the aforementioned services | ACTIVE | — |
| 042 | Research and development services in the field of new biological, pharmaceutical, biopharmaceutical, chemical and medical products; technological consultancy, namely, providing consultancy and expert assistance in the field of new product development of medicines and pharmaceutical products, and laboratory analysis in the field of medicines and pharmaceuticals; research, development and laboratory analysis services relating to pharmaceutical and medicinal goods, in particular, albumin, chemicals, peptides, proteins, antibodies, cells, nucleic acids, viruses, live viruses, live-attenuated viruses, attenuated viruses, virus-like particles and viral vectors; quality management services, namely, quality evaluation and analysis, quality assurance, and quality control in the field of pharmaceutical, biopharmaceutical, chemical, and medical products; certification, namely, quality control services in the field of biological, pharmaceutical, biopharmaceutical, chemical, and medical products; certification, namely, quality assurance services in the field of biological, pharmaceutical, biopharmaceutical, chemical, and medical products; process monitoring, namely, quality assurance in the field of biological, pharmaceutical, biopharmaceutical, chemical, and medical products; quality control services for others in the field of development and testing of cells; services of a scientific chemical and biological laboratory; development and testing of chemical, pharmaceutical, biopharmaceutical, chemical, and medical production methods; quality control services for others and authentication services in the field of biological, pharmaceutical, biopharmaceutical, chemical, and medical products; process monitoring, namely, providing quality assurance services in the field of biological, pharmaceutical, biopharmaceutical, chemical, and medical products; scientific and medical laboratory services; information, consultancy and advisory services for research, testing, and development in the pharmaceutical, biopharmaceutical, chemical, and medical fields, none of the foregoing related to financial software | ACTIVE | — |
| 045 | Regulatory compliance auditing; regulatory compliance consultancy in the field of biotechnology, pharmaceuticals, biopharmaceuticals, and medical testing and research; reviewing standards and practices to assure compliance with laws and regulations in the fields of biology, pharmaceuticals, biopharmaceuticals, chemicals, and medicine; information, consultancy and advisory services for the aforementioned services | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Albumedix Ltd
- Other trademarks owned by Albumedix Ltd
- Other trademarks owned by Sartorius Albumedix Limited
- Other trademarks owned by Albumedix Ltd
- Other trademarks in Class 041
- Other trademarks in Class 042
- Other trademarks in Class 045
- Similar marks named ALEVATE
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| May 31, 2025 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Apr 25, 2025 | XXSS | GENERIC MADRID TRANSACTION SENT TO IB | — |
| Apr 25, 2025 | XXCR | GENERIC MADRID TRANSACTION CREATED | — |
| Apr 16, 2025 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Apr 16, 2025 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Apr 16, 2025 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Apr 16, 2025 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Apr 16, 2025 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Apr 11, 2025 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| Mar 3, 2025 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Dec 3, 2024 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Dec 3, 2024 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Oct 1, 2024 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Oct 1, 2024 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Sep 11, 2024 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Aug 28, 2024 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jun 24, 2024 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jun 24, 2024 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jun 24, 2024 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Mar 18, 2024 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Feb 28, 2024 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Feb 28, 2024 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Dec 31, 2023 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Dec 31, 2023 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Dec 31, 2023 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Nov 3, 2023 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Nov 3, 2023 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Nov 3, 2023 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| May 24, 2023 | RFNT | REFUSAL PROCESSED BY IB | — |
| May 4, 2023 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| May 4, 2023 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Apr 2, 2023 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Mar 16, 2023 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Mar 15, 2023 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 7, 2023 | DOCK | ASSIGNED TO EXAMINER | — |
| Jan 29, 2023 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Sep 27, 2022 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Sep 23, 2022 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Sep 22, 2022 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |